ABBV
46
-4
LYB
11
-2
BIIB
52
-4
AFL
39
-2
EMN
50
-5
AN
61
-2
AVY
47
-3
CA
24
3
BLK
58
-2
ALL
50
-3
BDX
55
-5
CLX
50
-3
CB
61
3
BMY
69
-2
CHD
31
-4
VIX
43
8
BEN
46
-2
AA
69
-3
MAR
53
-6
ADM
45
-3
ABBV
46
-4
LYB
11
-2
BIIB
52
-4
AFL
39
-2
EMN
50
-5
AN
61
-2
AVY
47
-3
CA
24
3
BLK
58
-2
ALL
50
-3
BDX
55
-5
CLX
50
-3
CB
61
3
BMY
69
-2
CHD
31
-4
VIX
43
8
BEN
46
-2
AA
69
-3
MAR
53
-6
ADM
45
-3
Financhill
Back

Structure Therapeutics, Inc. 10K Form

Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.99
Seasonality Move:
-31.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GPCR News And Ratings

See the #1 stock for the next 7 days that we like better than GPCR

GPCR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-52.6M
Price / Cash Flow: 0
Annual Sales: $12.69
Price / Book: 5.23

Profitability

EPS (TTM): -3.65250
Net Income (TTM): $-210.9M
Gross Margin: $-2.6M
Return on Equity: -25.55%
Return on Assets: -24.24%

Structure Therapeutics, Inc. Earnings Forecast

Key Structure Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 1 years.

Structure Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GPCR
Website: structuretx.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 14.15
Quick Ratio: 13.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GPCR Technical Analysis vs Fundamental Analysis

Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy or a Sell?